Ticker ARVN – Arvinas – sales, description, marketcap – Tickerday.com

ARVN

Arvinas

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 922.47M; Volume: 419.97K; AvgVol 3m: 368.24K; Beta: –;

Cost estimate:

P/E: –; EPS: -2.34; EPS growth quarter/prev quarter: -19.30%;

EPS growth this year: 72.20%; EPS growth past 5 years: ;

EPS ttm: -2.34;

P/S: 41.13; P/B: 4.77; P/Cashflow: 7.95; P/FCF: ;

Sales: 46.93M; Sales growth quarter/prev quarter: 42.50%; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -32.50%; ROE – return on equity: -44.50%; LT Debt/Equity: 0.01; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 0.60%; Insider Transactions:-1.30%;

Institutional Ownership: 93.30%; Institutional Transactions: 5.81%;

Data update: 07/10/2020.